Antiviral activity of merimepodib against foot and mouth disease virus in vitro and in vivo.
Antiviral activity
FMDV
In vivo
Merimepodib
Journal
Molecular immunology
ISSN: 1872-9142
Titre abrégé: Mol Immunol
Pays: England
ID NLM: 7905289
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
06
03
2019
revised:
04
05
2019
accepted:
25
07
2019
pubmed:
7
8
2019
medline:
22
1
2020
entrez:
7
8
2019
Statut:
ppublish
Résumé
Foot and mouth disease virus (FMDV), a member of family Picornaviridae, belongs to the genus Aphthovirus, which causes foot and mouth disease (FMD), a highly transmissible disease that affects cloven-hoof animals. In spite of the fact that efficient vaccines are available, effective antiviral molecules for FMD are needed to reduce viral infection during early stages of infection. In this study, merimepodib was found to efficiently inhibit FMDV replication in a dose-dependent manner. The 50% inhibitory concentration (IC
Identifiants
pubmed: 31386979
pii: S0161-5890(19)30177-4
doi: 10.1016/j.molimm.2019.07.021
pii:
doi:
Substances chimiques
Antiviral Agents
0
Carbamates
0
N-3-(3-(3-methoxy-4-oxazol-5-ylphenyl)ureido)benzylcarbamic acid tetrahydrofuran-3-yl ester
0
Phenylurea Compounds
0
Viral Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
226-232Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.